Furthermore, whereas peripheral CD8+ T cells express little to no CD25, tumor-infiltrating CD8+ T cells greatly upregulate CD25 on antigen recognition, enabling them to effectively compete with Tregs for IL-2. This evidence concerns the gene IL2RA and neoplasm.